12.89% Less Zomedica Pharmaceuticals Corphares (NYSEAMERICAN:ZOM) Shares Shorted

It was registered a decrease on Zomedica Pharmaceuticals Corphares (NYSEAMERICAN:ZOM)’s shares shorted with 12.89%. In December was issued ZOM’s total 1.20M shares shorted by FINRA. That’s 12.89% down from 1.37 million shares. Zomedica Pharmaceuticals Corphares (NYSEAMERICAN:ZOM) has 31,100 shares average volume. It’ll cost 39 days for ZOM to recover its former position. 3.33% is Zomedica Pharmaceuticals Corphares float short.

The stock decreased 5.10% or $0.08 during the last trading session, hitting $1.49.Zomedica Pharmaceuticals Corp. is after having 0.00% since December 8, 2017. ZOM has 47,447 volume or 73.84% up from normal. ZOM underperformed the S&P500 by 15.62%.

Zomedica Pharmaceuticals Corp. operates as a veterinary pharmaceutical firm in the United States.The firm is valued at $163.33 million. It focuses on the discovery, development, and commercialization of drugs, novel drug delivery systems, devices, and diagnostics for the health and wellness of companion animals, such as canine, feline, and equine.Currently it has negative earnings. The firm has a research collaboration agreement with Celsee Diagnostics, Inc. to test the feasibility of Celsee's liquid biopsy technology for veterinary application as a canine cancer diagnostics.

For more Zomedica Pharmaceuticals Corp. (NYSEAMERICAN:ZOM) news brought out briefly go to: Ft.com, Globenewswire.com, Globenewswire.com, Stockhouse.com or Globenewswire.com. The titles are as follows: “NYSE wins approval for ‘speed bump’ in trading – Financial Times” brought out on May 16, 2017, “Zomedica Announces Changes to Commercialization Leadership Team TSX Venture Exchange:ZOM – GlobeNewswire” on June 14, 2018, “DPW Holdings to Announce Second Quarter 2018 Financial Results on August 14; conference call set for August 15 – GlobeNewswire” with a publish date: July 17, 2018, “Shares of energy efficiency company set to break out and buck the market with big percentage gains – Stockhouse” and the last “Zomedica Signs Agreement With Seraph Biosciences for Innovative Veterinary Point-of-Care Diagnostic – GlobeNewswire” with publication date: May 10, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.